https://www.zacks.com/stock/news/2249999/manulife-mfc-shares-up-11-ytd-more-room-for-upside?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2249999
Apr 03, 2024 - Manulife (MFC) appears well-poised for growth on its strengthening Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position.
zc:3528573799276864810
0
https://www.zacks.com/stock/news/2249959/vanda-vnda-up-on-fda-nod-for-fanapt-in-bipolar-i-disorder?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249959
Apr 03, 2024 - Vanda (VNDA) announces the FDA's approval of Fanapt for the acute treatment of bipolar I disorder in adults. The stock rises 30.4%.
zc:-8253803401341297518
0
https://www.zacks.com/stock/news/2249972/msa-safety-msa-is-up-3-26-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2249972
Apr 03, 2024 - Does MSA Safety (MSA) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:1565135576607628017
0
https://www.zacks.com/stock/news/2249977/pagseguro-digital-ltd-pags-is-up-2-44-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2249977
Apr 03, 2024 - Does PagSeguro Digital Ltd. (PAGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:2647745652445645788
0
https://www.zacks.com/stock/news/2249940/ubs-group-ubs-announces-a-new-share-repurchase-program?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2249940
Apr 03, 2024 - UBS Group (UBS) announces a new share repurchase program. The plan authorizes buyback of up to $2 billion worth of shares.
zc:-5609043722195467280
0
https://www.zacks.com/stock/news/2250017/cognizant-ctsh-mccormik-team-up-for-digital-transformation?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2250017
Apr 03, 2024 - Cognizant transforms McCormik's technology infrastructure, enhancing user experiences globally with AI-powered solutions.
zc:371606488911310773
0
https://www.zacks.com/stock/news/2249898/evaxion-evax-up-on-upbeat-preclinical-s-aureus-vaccine-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249898
Apr 03, 2024 - Evaxion (EVAX) gains 20% on positive results from the pre-clinical studies of its EVX-B1 vaccine candidate in large non-rodent animals, which is being developed to treat S. aureus infection.
zc:-5209417547287787725
0
https://www.zacks.com/stock/news/2249894/humana-s-hum-medicaid-business-teams-up-with-cpesn-usa-in-ohio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249894
Apr 03, 2024 - Humana's (HUM) partnership with CPESN USA in Ohio aims to overcome barriers like limited access to healthcare services in rural and underserved communities.
zc:-2924741670505240704
0
https://www.zacks.com/stock/news/2250001/dave-buster-s-play-q4-earnings-miss-estimates-stock-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2250001
Apr 03, 2024 - Dave & Buster's (PLAY) fiscal fourth-quarter comps are impacted by unfavorable weather conditions, leading to multiple complete and partial store closures within the system.
zc:-2588588423974983366
0
https://www.zacks.com/stock/news/2249882/accenture-acn-to-snap-up-italy-s-intellera-consulting?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2249882
Apr 03, 2024 - The acquisition aligns with Accenture's (ACN) expansion plans and targeted investments in Italy.
zc:3389904802370754115
0